SEC Form D · filed October 7, 2022
Pharmaceutics International, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
John E. Fowler · Hunt Valley, MDExec · DirectorSana I. Abidi · Hunt Valley, MDDirectorJames E. Gale · Hunt Valley, MDDirectorDavid E. Solomon · Hunt Valley, MDDirectorMichael E. Bogda · Hunt Valley, MDDirectorSyed E. Abidi, Ph.D · Hunt Valley, MDDirectorJohn I. Guthrie · Hunt Valley, MDExecThomas Lapham · Kirkland, WADirectorJonathan J. Desimone · Boston, MADirectorViva F. Hyatt · Boston, MADirectorChao H. Cheng-Shorland · New York, NYDirectorJonathan Macey · Kirkland, WADirectorHabib L. Kairouz · New York, NYExecAndrew B. Clark · Toronto, Ontario, CanadaExec · DirectorJeffrey F. Robinson · Boston, MADirectorBrian F. Hirschfeld · Boston, MADirectorNicolas B. Poniatowski · New York, NYDirectorHugues J. De Braucourt · New York, NYExecRick H. Hurd · CHICAGO, ILDirectorErin H. Ankin · CHICAGO, ILDirectorJay Kahn · San Francisco, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗